As of Apr 29
| +0.02 / +0.70%|
The 7 analysts offering 12-month price forecasts for Conatus Pharmaceuticals Inc have a median target of 15.00, with a high estimate of 17.00 and a low estimate of 6.00. The median estimate represents a +422.65% increase from the last price of 2.87.
The current consensus among 7 polled investment analysts is to Buy stock in Conatus Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.